Market Cap 472.26M
Revenue (ttm) 965.41M
Net Income (ttm) -284.28M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -29.45%
Debt to Equity Ratio -20.11
Volume 113,100
Avg Vol 119,742
Day's Range N/A - N/A
Shares Out 16.55M
Stochastic %K 53%
Beta 0.76
Analysts Strong Sell
Price Target $39.80

Company Profile

Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers claims intelligence solutions, including reference-based pricing, negotiation services, surprise bill services, and Vistara; network solutions, such as primary networks, complementary networks, and network build and network management services; and payment and r...

Industry: Health Information Services
Sector: Healthcare
Phone: 212 780 2000
Address:
7900 Tysons One Place, Suite 400, McLean, United States
LewisDaKat
LewisDaKat May. 11 at 8:00 PM
$CTEV Claritev Corporation Announces Participation in BofA Securities Global Health Care Conference 2026 https://marketwirenews.com/stock/ctev/news/claritev-corporation-announces-participation-in-bofa-4525466048250192.html?utm_source=stocktwits
0 · Reply
MarketBeat
MarketBeat May. 9 at 11:04 PM
https://marketbeat.com/a/8644556/ $CTEV Claritev Q1 Earnings Call Highlights
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 7 at 10:15 AM
$CTEV Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$4.41 down -0.68% YoY • Reported revenue of $244.68M up 5.77% YoY • Claritev updated its full-year 2026 revenue guidance to a range of $985M to $1B, up from the prior $980M to $1B, while maintaining Adjusted EBITDA, capital expenditures, and Free Cash Flow guidance.
0 · Reply
AllenCliverson
AllenCliverson Apr. 18 at 5:26 PM
0 · Reply
SuperGreenToday
SuperGreenToday Apr. 8 at 3:18 PM
$CTEV Share Price: $17.52 Contract Selected: Oct 16, 2026 $15 Calls Buy Zone: $4.50 – $5.57 Target Zone: $8.57 – $10.48 Potential Upside: 80% ROI Time to Expiration: 190 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
focafoca99
focafoca99 Mar. 17 at 6:31 AM
$CTEV used Investor Day to talk long-term prospects and guidance, which tells me management wanted to frame the story beyond one quarter.
0 · Reply
Stock44444444
Stock44444444 Mar. 4 at 11:58 PM
Another epic day for $ASTS and $CTEV
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Mar. 2 at 11:40 PM
$CTEV CEO purchased 15,380 shares at $13.00 for a total of $199,928. Dalton Travis now owns 268,010 shares. https://ceo-buys.com
0 · Reply
Stock44444444
Stock44444444 Mar. 2 at 10:57 PM
$CTEV nice day along with $ASTS
0 · Reply
Latest News on CTEV
Claritev price target raised to $40 from $21 at Citi

2026-05-13T19:19:16.000Z - 11 hours ago

Claritev price target raised to $40 from $21 at Citi


Claritev launches PHCS Novera solution

2026-05-13T14:47:42.000Z - 16 hours ago

Claritev launches PHCS Novera solution


Claritev Earnings Call Transcript: Q1 2026

May 7, 2026, 8:00 AM EDT - 6 days ago

Claritev Earnings Call Transcript: Q1 2026


Claritev reports Q1 EPS ($4.41) vs. ($4.38) last year

2026-05-07T11:13:22.000Z - 6 days ago

Claritev reports Q1 EPS ($4.41) vs. ($4.38) last year


Claritev Corporation Reports First Quarter 2026 Results

May 7, 2026, 6:00 AM EDT - 6 days ago

Claritev Corporation Reports First Quarter 2026 Results


Claritev Transcript: AGM 2026

Apr 29, 2026, 9:00 AM EDT - 14 days ago

Claritev Transcript: AGM 2026


Claritev initiated with an Overweight at Barclays

2026-04-24T08:35:12.000Z - 19 days ago

Claritev initiated with an Overweight at Barclays


Claritev Transcript: Investor Day 2026

Mar 16, 2026, 1:00 PM EDT - 2 months ago

Claritev Transcript: Investor Day 2026


Claritev Transcript: Status update

Mar 6, 2026, 11:00 AM EST - 2 months ago

Claritev Transcript: Status update


Claritev Corporation Announces Participation in Upcoming Events

Mar 4, 2026, 8:00 AM EST - 2 months ago

Claritev Corporation Announces Participation in Upcoming Events


Claritev Corporation To Host 2026 Investor Day

Mar 3, 2026, 1:58 PM EST - 2 months ago

Claritev Corporation To Host 2026 Investor Day


Claritev price target lowered to $21 from $63 at Citi

2026-02-25T11:30:39.000Z - 2 months ago

Claritev price target lowered to $21 from $63 at Citi


Claritev price target lowered to $30 from $33 at Wells Fargo

2026-02-24T11:42:50.000Z - 2 months ago

Claritev price target lowered to $30 from $33 at Wells Fargo


Claritev price target lowered to $38 from $43 at Guggenheim

2026-02-24T11:30:14.000Z - 2 months ago

Claritev price target lowered to $38 from $43 at Guggenheim


Claritev Earnings Call Transcript: Q4 2025

Feb 23, 2026, 4:30 PM EST - 2 months ago

Claritev Earnings Call Transcript: Q4 2025


Claritev sees FY26 revenue $980M-$1B, consensus $996.42M

2026-02-23T21:22:12.000Z - 2 months ago

Claritev sees FY26 revenue $980M-$1B, consensus $996.42M


Claritev reports Q4 EPS ($4.88) vs ($8.53) last year

2026-02-23T21:10:47.000Z - 2 months ago

Claritev reports Q4 EPS ($4.88) vs ($8.53) last year


Claritev enters strategic relationship with Kinetiq Health

2026-01-21T13:17:05.000Z - 4 months ago

Claritev enters strategic relationship with Kinetiq Health


Claritev Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 15, 2026, 10:30 AM EST - 4 months ago

Claritev Transcript: 44th Annual J.P. Morgan Healthcare Conference


Claritev price target lowered to $63 from $80 at Citi

2026-01-09T12:16:19.000Z - 4 months ago

Claritev price target lowered to $63 from $80 at Citi


Claritev initiated with an Equal Weight at Wells Fargo

2026-01-08T21:26:02.000Z - 4 months ago

Claritev initiated with an Equal Weight at Wells Fargo


Claritev 1.5M share Spot Secondary priced at $51.50

2025-11-13T04:25:11.000Z - 6 months ago

Claritev 1.5M share Spot Secondary priced at $51.50


Claritev management to meet virtually with Piper Sandler

2025-11-10T20:55:09.000Z - 6 months ago

Claritev management to meet virtually with Piper Sandler


Claritev price target raised to $90 from $86 at Piper Sandler

2025-11-10T12:05:16.000Z - 6 months ago

Claritev price target raised to $90 from $86 at Piper Sandler


Claritev price target raised to $80 from $74 at Citi

2025-11-10T11:46:00.000Z - 6 months ago

Claritev price target raised to $80 from $74 at Citi


Claritev Earnings Call Transcript: Q3 2025

Nov 7, 2025, 8:00 AM EST - 6 months ago

Claritev Earnings Call Transcript: Q3 2025


Claritev reports Q3 EPS ($4.23) vs. ($24.25) last year

2025-11-07T11:25:59.000Z - 6 months ago

Claritev reports Q3 EPS ($4.23) vs. ($24.25) last year


Claritev raises FY25 revenue view to 2.8%-3.2% from Flat to 2%

2025-11-07T11:25:34.000Z - 6 months ago

Claritev raises FY25 revenue view to 2.8%-3.2% from Flat to 2%


Claritev Corporation Reports Third Quarter 2025 Results

Nov 7, 2025, 6:00 AM EST - 6 months ago

Claritev Corporation Reports Third Quarter 2025 Results


Claritev Earnings Call Transcript: Q2 2025

Aug 6, 2025, 8:00 AM EDT - 10 months ago

Claritev Earnings Call Transcript: Q2 2025


Claritev Corporation Reports Second Quarter 2025 Results

Aug 6, 2025, 6:00 AM EDT - 10 months ago

Claritev Corporation Reports Second Quarter 2025 Results


Claritev Releases 2024 Corporate Responsibility Report

Jul 16, 2025, 9:00 AM EDT - 10 months ago

Claritev Releases 2024 Corporate Responsibility Report


Claritev Earnings Call Transcript: Q1 2025

May 8, 2025, 8:00 AM EDT - 1 year ago

Claritev Earnings Call Transcript: Q1 2025


Claritev Corporation Reports First Quarter 2025 Results

May 8, 2025, 6:00 AM EDT - 1 year ago

Claritev Corporation Reports First Quarter 2025 Results


Claritev Appoints Jason Kap to its Board of Directors

May 1, 2025, 8:00 AM EDT - 1 year ago

Claritev Appoints Jason Kap to its Board of Directors


LewisDaKat
LewisDaKat May. 11 at 8:00 PM
$CTEV Claritev Corporation Announces Participation in BofA Securities Global Health Care Conference 2026 https://marketwirenews.com/stock/ctev/news/claritev-corporation-announces-participation-in-bofa-4525466048250192.html?utm_source=stocktwits
0 · Reply
MarketBeat
MarketBeat May. 9 at 11:04 PM
https://marketbeat.com/a/8644556/ $CTEV Claritev Q1 Earnings Call Highlights
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 7 at 10:15 AM
$CTEV Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$4.41 down -0.68% YoY • Reported revenue of $244.68M up 5.77% YoY • Claritev updated its full-year 2026 revenue guidance to a range of $985M to $1B, up from the prior $980M to $1B, while maintaining Adjusted EBITDA, capital expenditures, and Free Cash Flow guidance.
0 · Reply
AllenCliverson
AllenCliverson Apr. 18 at 5:26 PM
0 · Reply
SuperGreenToday
SuperGreenToday Apr. 8 at 3:18 PM
$CTEV Share Price: $17.52 Contract Selected: Oct 16, 2026 $15 Calls Buy Zone: $4.50 – $5.57 Target Zone: $8.57 – $10.48 Potential Upside: 80% ROI Time to Expiration: 190 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
focafoca99
focafoca99 Mar. 17 at 6:31 AM
$CTEV used Investor Day to talk long-term prospects and guidance, which tells me management wanted to frame the story beyond one quarter.
0 · Reply
Stock44444444
Stock44444444 Mar. 4 at 11:58 PM
Another epic day for $ASTS and $CTEV
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Mar. 2 at 11:40 PM
$CTEV CEO purchased 15,380 shares at $13.00 for a total of $199,928. Dalton Travis now owns 268,010 shares. https://ceo-buys.com
0 · Reply
Stock44444444
Stock44444444 Mar. 2 at 10:57 PM
$CTEV nice day along with $ASTS
0 · Reply